According to ESSA Pharma's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$34.23 Million USD a decrease over its 2023 earnings that were of -$27.64 Million USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | -$31.06 Million | -9.24% |
2024 | -$34.23 Million | 23.83% |
2023 | -$27.64 Million | -15.87% |
2022 | -$32.85 Million | -16.52% |
2021 | -$39.35 Million | 57.5% |
2020 | -$24.99 Million | 109.01% |
2019 | -$11.96 Million | 5.15% |
2018 | -$11.37 Million | 62.81% |
2017 | -$6.99 Million | 6.45% |
2016 | -$6.56 Million | -43.02% |
2015 | -$11.52 Million | 310.75% |
2014 | -$2.81 Million |